Galecto Inc (GLTO)
6.85
-0.04
(-0.58%)
USD |
NASDAQ |
Nov 14, 16:00
6.85
0.00 (0.00%)
After-Hours: 18:31
Galecto Enterprise Value: -10.60M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | -10.60M |
| November 12, 2024 | -10.46M |
| November 11, 2024 | -10.35M |
| November 08, 2024 | -10.34M |
| November 07, 2024 | -10.12M |
| November 06, 2024 | -10.47M |
| November 05, 2024 | -10.64M |
| November 04, 2024 | -10.81M |
| November 01, 2024 | -10.79M |
| October 31, 2024 | -10.66M |
| October 30, 2024 | -10.05M |
| October 29, 2024 | -10.36M |
| October 28, 2024 | -10.12M |
| October 25, 2024 | -10.11M |
| October 24, 2024 | -10.13M |
| October 23, 2024 | -10.65M |
| October 22, 2024 | -10.65M |
| October 21, 2024 | -10.42M |
| October 18, 2024 | -10.31M |
| October 17, 2024 | -10.82M |
| October 16, 2024 | -10.84M |
| October 15, 2024 | -10.82M |
| October 14, 2024 | -10.40M |
| October 11, 2024 | -10.11M |
| October 10, 2024 | -10.57M |
| Date | Value |
|---|---|
| October 09, 2024 | -10.25M |
| October 08, 2024 | -9.818M |
| October 07, 2024 | -8.535M |
| October 04, 2024 | -5.034M |
| October 03, 2024 | -4.833M |
| October 02, 2024 | -5.385M |
| October 01, 2024 | -5.046M |
| September 30, 2024 | -4.444M |
| September 27, 2024 | -8.244M |
| September 26, 2024 | -8.344M |
| September 25, 2024 | -8.419M |
| September 24, 2024 | -8.207M |
| September 23, 2024 | -7.857M |
| September 20, 2024 | -6.310M |
| September 19, 2024 | -5.636M |
| September 18, 2024 | -5.723M |
| September 17, 2024 | -5.274M |
| September 16, 2024 | -6.934M |
| September 13, 2024 | -6.722M |
| September 12, 2024 | -5.199M |
| September 11, 2024 | -6.484M |
| September 10, 2024 | -8.151M |
| September 09, 2024 | -10.46M |
| September 06, 2024 | -10.75M |
| September 05, 2024 | -10.39M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-62.78M
Minimum
May 24 2022
509.70M
Maximum
Nov 23 2020
13.58M
Average
-10.82M
Median
Sep 03 2024
Enterprise Value Benchmarks
| Novo Nordisk AS | 472.39B |
| Genmab AS | 11.17B |
| Ascendis Pharma AS | 7.975B |
| Evaxion Biotech AS | 5.018M |
| IO Biotech Inc | -36.84M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.883M |
| Total Expenses (Quarterly) | 3.84M |
| EPS Diluted (Quarterly) | -3.39 |
| Earnings Yield | -280.3% |